Caroline Dixon and Colleagues on LMWH Dosing to Reduce The Risk of VTE in Pregnant Women With Inherited ATD
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Anti-Xa–directed low-molecular-weight heparin dosing to reduce venous thromboembolism in pregnant women with inherited antithrombin deficiency
By Caroline Dixon, Karen Breen, Sue Robinson, Aine McCormick, and Professor Beverley Hunt OBE
• Challenge: Inherited antithrombin deficiency (ATD) markedly increases VTE risk during pregnancy, but LMWH efficacy depends on antithrombin levels.
• Approach: A single-centre cohort (32 pregnancies, 17 women) adopted anti-Xa-guided LMWH dosing with selective peripartum antithrombin concentrate.
• Outcome: Overall VTE rate was 12.5%, yet no VTE occurred in adherent women receiving anti-Xa–adjusted LMWH. Haemorrhage risk remained acceptable (12.5%, mostly moderate).”
Read the full article in JTH.
Article: Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency
Authors: Caroline Dixon, Karen Breen, Susan Robinson, Aine McCormick, Beverley J. Hunt
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Oct 13, 2025, 03:32Wolfgang Miesbach: This Study from Children's Hospital of Philadelphia Provides Crucial Insights Into Elevidys
-
Oct 13, 2025, 02:47Thomas Reiser: Don't Miss This ISTH Research Recap with Robert Sidonio, Cedric Hermans and Michael Makris
-
Oct 12, 2025, 01:30Elvira Grandone: Pregnancy and VTE - Still A Relevant Cause of Maternal Mortality
-
Oct 12, 2025, 01:29Emilia Arturo: Consider Submitting the Paper and Its Reviews for a Second Look Rapid Response From One of These Blood Journals
-
Oct 12, 2025, 01:22Christina (Tina) P.: APS is Responsible for 1 in 3 Strokes in People Under 50 and The N1 Cause of Stroke in Young People
-
Oct 13, 2025, 02:43Lukas Meyer and Colleagues on Reperfusion-dependent Treatment Effects of Thrombectomy in Large Ischemic Infarcts
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 12, 2025, 01:32Camila V. Blair and Colleagues on The Association of CAD by Coronary CT Angiography and Cardiovascular Outcomes in Psoriatic Disease
-
Oct 12, 2025, 01:26Caroline Dixon and Colleagues on LMWH Dosing to Reduce The Risk of VTE in Pregnant Women With Inherited ATD
-
Oct 12, 2025, 01:26Nagesh Ramesh: 80% of The World’s Population Lives in LMICs But They Collect Less Than 10% of The World’s Plasma
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 13, 2025, 03:15Arun V. J: They Chose Death Over A Blood Transfusion — And Here’s Why I Stopped Judging Them
-
Oct 13, 2025, 03:13Rahaf Ajaj: The Persistent Gender Gap in Nobel Prizes - A Call for Greater Inclusion
-
Oct 13, 2025, 02:50Emmanuel J Favaloro: Again Promoting World Thrombosis Day - October 13
-
Oct 12, 2025, 01:33Stefan Galisch: This Week We Celebrate IPAW– A Global Initiative That Raises Awareness of The Life-saving Importance of Plasma Donation
-
Oct 12, 2025, 01:31Fabio Eisfeld: Plasma-derived Drugs Cannot Be Produced Synthetically, They Depend Entirely On The Generosity of Healthy Donors